TREATMENT OF ANEMIA RESISTANT TO CONVENTIONAL ERYTHROPOIETIN THERAPY WITH THYMOPENTIN IN HEMODIALYSIS-PATIENTS

被引：3
|
作者：
RAIOLA, P [1 ]
MANZO, M [1 ]
SAGGESE, A [1 ]
TOMASINO, G [1 ]
CICCHELLA, T [1 ]
RAMBALDI, M [1 ]
PISANO, M [1 ]
LIZZA, B [1 ]
PERNA, AF [1 ]
机构：
[1] UNIV NAPLES 2,SCH MED,DEPT PEDIAT,CHAIR NEPHROL,NAPLES,ITALY
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 1995年 / 10卷
关键词：
CHRONIC RENAL FAILURE; RESISTANT ANEMIA; ERYTHROPOIETIN; THYMOPENTIN;
D O I：
10.1093/ndt/10.supp6.48
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
引用
收藏
页码：48 / 50
页数：3
相关论文
共 50 条
  • [1] EFFECTS OF ERYTHROPOIETIN TREATMENT ON THYROID-DYSFUNCTION IN HEMODIALYSIS-PATIENTS WITH RENAL ANEMIA
    TOMODA, F
    TAKADA, M
    IZUMINO, K
    OHHASHI, S
    UENO, H
    IIDA, H
    NEPHRON, 1994, 66 (03) : 307 - 311
  • [2] ERYTHROPOIETIN TREATMENT IN HEMODIALYSIS-PATIENTS WITH IRON OVERLOAD
    ELRESHAID, K
    JOHNY, KV
    HAKIM, A
    KAMEL, H
    SEBETA, A
    HOURANI, H
    KANYIKE, FB
    ACTA HAEMATOLOGICA, 1994, 91 (03) : 130 - 135
  • [3] TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS WITH ERYTHROPOIETIN - LONG-TERM EFFECTS ON EXERCISE CAPACITY
    BARANY, P
    FREYSCHUSS, U
    PETTERSSON, E
    BERGSTROM, J
    CLINICAL SCIENCE, 1993, 84 (04) : 441 - 447
  • [4] ERYTHROPOIETIN TREATMENT AND AMINO-ACID-METABOLISM IN HEMODIALYSIS-PATIENTS
    GARIBOTTO, G
    GURRERI, G
    ROBAUDO, C
    SAFFIOTI, S
    MAGNASCO, A
    SOFIA, A
    MARCHELLI, M
    SALA, MR
    NEPHRON, 1993, 65 (04): : 533 - 536
  • [5] IS FOLATE SUPPLEMENTATION NECESSARY IN HEMODIALYSIS-PATIENTS ON ERYTHROPOIETIN THERAPY
    ONO, K
    HISASUE, Y
    CLINICAL NEPHROLOGY, 1992, 38 (05) : 290 - 292
  • [6] SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION OF ERYTHROPOIETIN IMPROVES ITS EFFICIENCY FOR THE TREATMENT OF ANEMIA IN HEMODIALYSIS-PATIENTS
    ALBITAR, S
    MEULDERS, Q
    HAMMOUD, H
    SOUTIF, C
    BOUVIER, J
    POLLINI, J
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 : 40 - 43
  • [7] Management of anemia in erythropoietin-resistant hemodialysis patients
    Santos, AED
    Shalansky, KF
    Jastrzebski, JP
    ANNALS OF PHARMACOTHERAPY, 2003, 37 (12) : 1768 - 1773
  • [8] ERYTHROPOIETIN FOR ANEMIA IN HEMODIALYSIS-PATIENTS - RESULTS OF A MAINTENANCE STUDY (THE CANADIAN-ERYTHROPOIETIN-STUDY-GROUP)
    MUIRHEAD, N
    LAUPACIS, A
    WONG, C
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1992, 7 (08) : 811 - 816
  • [9] EVALUATION OF HEMODIALYSIS-PATIENTS TREATED WITH ERYTHROPOIETIN
    ACCHIARDO, SR
    QUINN, BP
    MOORE, LW
    BURK, LB
    MILES, DE
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1991, 17 (03) : 290 - 294
  • [10] ERYTHROPOIESIS AND ERYTHROCYTE AGE DISTRIBUTION IN HEMODIALYSIS-PATIENTS UNDERGOING ERYTHROPOIETIN THERAPY
    HAMPL, H
    RIEDEL, E
    SCIGALLA, P
    STABELL, U
    WENDEL, G
    BLOOD PURIFICATION, 1990, 8 (03) : 117 - 125
12345